GridAI Technologies (GRDX) Free Cash Flow (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Free Cash Flow came in at -$4.0 million in Q4 2025, down 2216.74% YoY from $187723.9 in Q4 2024, and down 364.38% on a QoQ basis from -$855688.0 in Q3 2025.
GridAI Technologies (GRDX) Free Cash Flow (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Free Cash Flow data on file, last reported at -$4.0 million in Q4 2025.
- Quarterly Free Cash Flow fell 2216.74% year-over-year to -$4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 38.13% YoY) and the FY2025 annual result came in at -$5.7 million, up 38.13% from the prior year.
- Free Cash Flow eased to -$4.0 million in Q4 2025, from -$855688.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$54878.0 in Q2 2025 to a low of -$15.7 million in Q3 2021.
- A 5-year average of -$4.1 million and a median of -$3.6 million in 2024 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 98.41% in 2025, down 2216.74% in 2025.
- Tracing GRDX's Free Cash Flow over 5 years: stood at -$5.9 million in 2021, then grew by 4.58% to -$5.6 million in 2022, then surged by 38.5% to -$3.4 million in 2023, then soared by 95.01% to -$171518.0 in 2024, then tumbled by 2216.74% to -$4.0 million in 2025.
- The last three Free Cash Flow figures came in at -$4.0 million (Q4 2025), -$855688.0 (Q3 2025), and -$54878.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | -3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.97 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Sep 30, 2025 | -855,688.00 |
| Sep 30, 2025 | -855,688.00 |
| Jun 30, 2025 | -54,878.00 |
| Jun 30, 2025 | -54,878.00 |
| Mar 31, 2025 | -818,635.00 |
| Mar 31, 2025 | -818,635.00 |
| Dec 31, 2024 | -171,518.00 |
| Dec 31, 2024 | -171,518.00 |
| Sep 30, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.85 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | -3.75 Mn |
| Mar 31, 2024 | -3.75 Mn |
| Dec 31, 2023 | -3.44 Mn |
| Dec 31, 2023 | -3.44 Mn |
| Sep 30, 2023 | -3.33 Mn |
| Sep 30, 2023 | -3.33 Mn |